ANALGESICS, DIURETICS, AND RENAL CELL CARCINOMA
镇痛药、利尿剂和肾细胞癌
基本信息
- 批准号:6236366
- 负责人:
- 金额:$ 6.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-04-01 至 1999-03-31
- 项目状态:已结题
- 来源:
- 关键词:acetaminophen analgesics anorexic agent antiinflammatory agents aspirin caffeine cancer registry /resource cancer risk coffee diuretics dosage drug administration rate /duration drug adverse effect drug related neoplasm /cancer human subject iatrogenic disease interview longitudinal human study medical records neoplasm /cancer epidemiology nutrition related neoplasm /cancer nutrition related tag occupational hazard questionnaires renal cell carcinoma smoking statistics /biometry
项目摘要
We propose to continue an ongoing population-based case-control study of
renal cell carcinoma in Los Angeles County. The primary aims are: (1) to
investigate the relationship between renal cell carcinoma and regular use
of analgesics, especially those containing aspirin or other non-steroidal
anti-inflammatory agents, or acetaminophen; and (2) to confirm and examine
in detail our earlier findings of an association between use of diuretics
and diet pills and renal cell carcinoma. The secondary aims are: (1) to
further evaluate the association of renal cell carcinoma with cigarette
smoking; (2) to determine whether coffee consumption is directly related to
an increased risk of renal cell carcinoma; (3) to investigate the possible
association between diet and renal cell carcinoma development, especially
the consumption of foods rich in nitrosamines or their precursors
(enhancing risk) and foods rich in vitamins A and C, and various
carotenoids (reducing risk); and (4) to investigate the possible
association between occupation and risk of renal cell carcinoma. All
histologically confirmed cases of renal cell carcinoma diagnosed between
April 1, 1986 and September 30, 1995 who are aged 25-74 years and either
Black or White will be asked to participate in this study. Controls will
be individually matched to the index case on race, sex, and age (within 5
years), and chosen according to a well-defined procedure from the
neighborhood of the index case's residence at the time of cancer diagnosis.
We expect to interview about 1280 case-control pairs of renal cell
carcinoma.
我们建议继续进行一项以人群为基础的病例对照研究
洛杉矶县的肾细胞癌。主要目标是:(1)
探讨肾癌与常规用药的关系
止痛药,尤指含有阿司匹林或其他非类固醇的止痛药
抗炎药或对乙酰氨基酚;以及(2)确认和检查
更详细地说,我们早先发现利尿剂的使用与
减肥药和肾癌。次要目标是:(1)
进一步评价肾细胞癌与香烟的关系
吸烟;(2)确定咖啡摄入量是否与
增加患肾细胞癌的风险;(3)调查
饮食与肾癌发生的关系,尤其是
食用富含亚硝胺或其前体的食物
(增加风险)和富含维生素A和C的食物,以及各种
类胡萝卜素(降低风险);和(4)研究可能的
职业与肾癌发病风险的相关性研究全
经组织学证实的肾细胞癌病例诊断为
1986年4月1日和1995年9月30日,年龄25-74岁
黑人或白人将被邀请参加这项研究。控制将
在种族、性别和年龄方面分别与索引案例匹配(在5岁以内
年),并根据定义明确的程序从
在癌症诊断时,指示病例住所的邻近地区。
我们预计采访约1280对病例对照肾细胞。
癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mimi C. Yu其他文献
Hepatitis B Virus, Aflatoxins, and Hepatocellular Carcinoma in Southern Guangxi, China1
中国广西南部的乙型肝炎病毒、黄曲霉毒素和肝细胞癌1
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
F. Yeh;Mimi C. Yu;C. Mo;S. Luo;M. Tong;B. Henderson - 通讯作者:
B. Henderson
On previous findings concerning preserved meat intake and respiratory disease.
关于之前关于腌制肉类摄入和呼吸道疾病的发现。
- DOI:
10.1164/ajrccm.176.3.315 - 发表时间:
2007 - 期刊:
- 影响因子:24.7
- 作者:
L. Butler;W. Koh;Hin‐Peng Lee;M. Tseng;Mimi C. Yu;S. London - 通讯作者:
S. London
Dietary β-carotene, cigarette smoking, and lung cancer in men
- DOI:
10.1007/bf00124253 - 发表时间:
1992-05-01 - 期刊:
- 影响因子:2.100
- 作者:
Atsuko Shibata;Annlia Paganini-Hill;Ronald K. Ross;Mimi C. Yu;Brian E. Henderson - 通讯作者:
Brian E. Henderson
Anthropometric, Dietary, and Hormonal Correlates of Serum Adiponectin in Asian American Women
亚裔美国女性血清脂联素的人体测量、饮食和激素相关性
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
A. Wu;Mimi C. Yu;F. Stanczyk;C. Tseng;M. Pike - 通讯作者:
M. Pike
Short Communication Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study 1
简短交流膳食大豆与膀胱癌风险增加:新加坡华人健康研究 1
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
Can‐lan Sun;Jian;Kazuko Arakawa;S. Low;Hin‐Peng Lee;Mimi C. Yu - 通讯作者:
Mimi C. Yu
Mimi C. Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mimi C. Yu', 18)}}的其他基金
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 6.2万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 6.2万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 6.2万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 6.2万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 6.2万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 6.2万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 6.2万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 6.2万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 6.2万 - 项目类别:














{{item.name}}会员




